Nordic 8 - A Phase II Trial

NCT01867697 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

173

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Cetuximab
DRUG: Irinotecan
DRUG: Oxaliplatin
DRUG: Folinic Acid
DRUG: Calcium Carbonate

Sponsor

Per Pfeiffer

Collaborators

[object Object]